Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Biomarkers and potential therapeutic targets driving progression of non-alcoholic steatohepatitis to hepatocellular carcinoma predicted through transcriptomic analysis

4 Dec 2024

Abstract excerpt

Background: Non-alcoholic steatohepatitis (NASH) is the most prevalent chronic liver condition globally, with potential progression to cirrhosis, and even hepatocellular carcinoma (HCC). The increasing prevalence of NASH underscores the urgent need for advanced diagnostic and therapeutic strategies. Despite its widespread impact, effective treatments to prevent the progression of NASH remain elusive, highlighting...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Ferroptosis and cancer prognosis
Share to Hepatocellular Carcinoma Treatment and Prognosis
Share to Liver Disease Diagnosis and Treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 39697329
DOI: 10.3389/fimmu.2024.1502263

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Biomarkers and potential therapeutic targets driving progression of non-alcoholic steatohepatitis to hepatocellular carcinoma predicted through transcriptomic analysisPMID 39697329Read ↗

A robust gene expression signature for NASH in liver expression dataSemantic proximity Read ↗

Identification of Shared and Unique Key Biomarkers of Alcohol Liver Cirrhosis and Non-Alcoholic Steatohepatitis Through Machine Learning Network-Based AlgorithmsSemantic proximity Read ↗

Comprehensive Transcriptomic Analysis of Hepatocellular Carcinoma: Uncovering Shared and Unique Molecular Signatures Across Diverse EtiologiesSemantic proximity Read ↗

Integrative network-based analysis on multiple Gene Expression Omnibus datasets identifies novel immune molecular markers implicated in non-alcoholic steatohepatitisSemantic proximity Read ↗

Characterization of signature trends across the spectrum of non-alcoholic fatty liver disease using deep learning methodSemantic proximity Read ↗

Integrated Analysis of Multiple Microarray Studies to Identify Novel Gene Signatures in Non-alcoholic Fatty Liver DiseaseSemantic proximity Read ↗

Integration of deep learning-based histopathology and transcriptomics reveals key genes associated with fibrogenesis in patients with advanced NASHSemantic proximity Read ↗

Decoding Liver Cancer Prognosis: From Multi-omics Subtypes, Prognostic Models to Single Cell ValidationSemantic proximity Read ↗

Integration of transcriptomic analysis and multiple machine learning approaches identifies NAFLD progression-specific hub genes to reveal distinct genomic patterns and actionable targetsSemantic proximity Read ↗

Single cell sequencing and multiple machine learning identified CD2 and ITGAV as novel biomarkers for NASH-related fibrosisSemantic proximity Read ↗

Identification of hub genes and pathways in nonalcoholic steatohepatitis by integrated bioinformatics analysisSemantic proximity Read ↗

Stage-Specific Transcriptome Landscape of Hepatocellular Carcinoma: Insights from Super and Poor Survivors with Prognostic Signature IdentificationSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.